--- title: "The 7-Point IP Defensibility Test That Exposes Most Startup Portfolios" slug: ip-defensibility-assessment-framework date: 2026-05-12 url: https://beyondelevation.com/blog/post.html?slug=ip-defensibility-assessment-framework author: Hayat Amin site: Beyond Elevation --- # The 7-Point IP Defensibility Test That Exposes Most Startup Portfolios 83% of startup patent portfolios fail at least 4 of 7 defensibility criteria. Most founders discover this during due diligence — when it is too late to fix. An IP defensibility assessment is the single most important diagnostic a founder can run before fundraising, licensing, or exit conversations. Hayat Amin developed the 7-Point IP Defensibility Test after auditing hundreds of startup portfolios and finding the same structural failures repeated across industries. The test separates patents that generate revenue and deter competitors from patents that exist only to fill a slide in a pitch deck. Here is the exact framework [Beyond Elevation](https://beyondelevation.com) runs on every client portfolio — and why your score determines whether investors price your IP as an asset or ignore it entirely. ## What Is an IP Defensibility Assessment? An IP defensibility assessment is a structured diagnostic that evaluates whether your patents, trade secrets, and proprietary know-how actually create barriers competitors cannot work around. It goes beyond checking that patents exist — it measures whether those patents do commercial work. The assessment scores your portfolio against criteria that investors, acquirers, and licensing counterparties use to price IP value. Most founders confuse having patents with having defensibility. A patent on a feature nobody copies is not defensible — it is irrelevant. A patent on a feature every competitor needs and cannot design around is a weapon. The IP defensibility assessment distinguishes one from the other in quantifiable terms. Hayat Amin argues this distinction costs founders more money than any other IP mistake: "Founders spend $50K to $150K on patents and assume they have defensibility. They do not. They have paperwork. Defensibility requires that every claim maps to a revenue stream, a competitive threat, or a licensing opportunity." ## The Hayat Amin IP Defensibility 7-Point Test The IP Defensibility 7-Point Test scores a patent portfolio from 0 to 7 across the criteria that determine real-world commercial value. Each point is pass or fail. A score of 5 or above means your portfolio is investor-ready. Below 3 means your patents are liabilities dressed as assets. ### 1. Claim Breadth Do your patent claims cover the features customers actually pay for? Narrow claims drafted around implementation details are easy to design around. Broad claims that cover customer-facing functionality — the feature a buyer selects your product for — create genuine barriers. Beyond Elevation maps every claim against the product's revenue drivers to score this criterion. ### 2. Design-Around Difficulty A defensible patent forces competitors to spend 12 to 24 months and significant engineering resources developing an alternative that does not infringe. If a competent team can design around your claims in 90 days, the patent fails this point. The test measures difficulty by analysing prior art density, claim structure, and the number of viable alternative implementations. ### 3. Portfolio Density One patent is a speed bump. Seven patents covering different aspects of the same technology are a [patent moat](/blog/posts/what-is-a-patent-moat/). Portfolio density measures whether your IP creates layered protection — where designing around one claim forces the competitor into another. Companies with patent clusters command 2 to 3x higher licensing rates because circumvention becomes economically irrational. ### 4. Geographic Coverage A US-only patent portfolio leaves 60% of the global market unprotected. The test evaluates whether filings cover the jurisdictions where competitors manufacture, sell, or deploy products that practice your technology. At minimum, defensible portfolios cover the US, EU, and one major Asian market. ### 5. Remaining Patent Life Patents expire. A portfolio with 15 or more years of remaining life is an asset investors can underwrite. A portfolio with 5 years left is depreciating. The test flags patents approaching expiration and evaluates whether continuation filings or new applications can extend protection on core innovations. ### 6. Enforcement Track Record Patents that have survived inter partes review, reexamination, or litigation are worth significantly more than untested patents. Even one successful enforcement action increases portfolio credibility in licensing negotiations. Untested claims carry unknown invalidity risk that sophisticated buyers discount heavily. ### 7. Revenue Linkage The most important criterion. Does each patent connect to a specific revenue stream — product revenue it protects, licensing income it generates, or competitive advantage it preserves? Patents that cannot be tied to revenue are overhead. Patents that map directly to income are assets. This criterion separates portfolios valued in the millions from portfolios valued at zero. ## Why Do Most Startup Portfolios Score 2 Out of 7? Most startup portfolios score between 1 and 3 on the IP defensibility assessment because they were built without strategic direction. The failure patterns are predictable. **Vanity patents.** Founders patent features they are proud of rather than features competitors need. A patent on a novel UI animation scores zero on claim breadth and revenue linkage if no competitor cares about that animation. Strategic filing targets the innovations competitors cannot avoid — data processing methods, system architectures, and workflows that define the product category. **US-only filing.** Cash-strapped startups file only in the US to save money. This fails criterion 4 and creates an immediate licensing gap. International filing under the Patent Cooperation Treaty costs $4K to $8K upfront and preserves the option to enter key markets for 30 months. Skipping it destroys long-term portfolio value. **Narrow claims.** Patent attorneys who draft without strategic input write claims that describe exactly how the current product works. These narrow claims fail criterion 2 — a slight change in implementation avoids infringement entirely. Strategic claim drafting covers the functional outcome, not just the current method. **No revenue connection.** The most common failure. Founders file patents and never revisit them. Within two years the patent claims no longer map to the revenue-generating features of the product. The portfolio looks large on paper and scores zero on criterion 7. ## How Do Investors Use the IP Defensibility Assessment? Investors use IP defensibility as a pricing input at every stage from seed to exit. Companies with patents are 10.2x more likely to secure early-stage funding — but that stat applies to strategically defensible patents, not to patents filed without direction. During due diligence, sophisticated investors run their own version of a defensibility assessment. They evaluate claim breadth, check for design-around risk, verify geographic coverage, and test revenue linkage. Founders who have already scored their own portfolio have a significant advantage — they can pre-empt investor concerns and frame the portfolio as a managed strategic asset rather than an afterthought. Hayat Amin reminds founders that investors do not buy ideas — they buy reasons an idea cannot be copied. "A patent is the cheapest proof of defensibility you can hand an investor. But only if the claims cover something a competitor needs. The 7-Point Test is how you know the difference before the investor tells you." In M&A, the IP defensibility assessment directly affects the acquisition premium. Portfolios scoring 5 or above on the 7-Point Test consistently command 2 to 4x higher multiples than portfolios scoring below 3. The assessment turns subjective IP value claims into an objective score acquirers can underwrite. ## How Does Beyond Elevation Run the IP Defensibility Assessment? [Beyond Elevation](https://beyondelevation.com) runs the 7-Point IP Defensibility Test as a structured engagement that produces a scored portfolio with a clear remediation roadmap. The process follows four phases. **Phase 1 — Portfolio mapping.** Every patent, pending application, trade secret, and documented know-how asset is catalogued and mapped to the technology stack and product roadmap. **Phase 2 — Claim-level analysis.** Each patent's claims are evaluated against the 7 criteria. Claim charts map assertions to specific product features and competitor products. Design-around analysis estimates circumvention cost and timeline. **Phase 3 — Commercial gap analysis.** The assessment identifies where the portfolio has gaps: revenue-generating features that lack patent protection, geographic markets without coverage, and innovations competitors are pursuing without IP barriers. **Phase 4 — Scoring and remediation roadmap.** Each patent receives a 0-to-7 score. The portfolio receives an aggregate defensibility rating. The roadmap prioritises filings, continuations, and trade secret programmes that close the highest-value gaps first — so every dollar of IP spend moves the score upward. Hayat Amin proved this process on a client portfolio where the founders valued their patents at $2M. After the 7-Point assessment revealed a score of 2, Beyond Elevation redesigned the filing strategy, added cluster coverage on core revenue-generating technology, and extended geographic protection. Eighteen months later the portfolio scored 6 and was valued at $14M in a licensing negotiation. The founders closed at $11M — a 5.5x increase driven entirely by strategic defensibility improvements. That is what an [IP strategy](/blog/posts/ip-strategy-startups-guide/) looks like when the assessment comes first and the legal spend follows the score. ## Run Your Own IP Defensibility Assessment Score your portfolio against the 7 criteria above. Be honest. If you score below 4, your IP spend is generating paperwork — not defensibility. The gap between your current score and a 5 is the gap between a portfolio that protects revenue and one that decorates a pitch deck. For the full Hayat Amin IP Defensibility 7-Point Test run by the team that built it, [book an IP defensibility assessment with Beyond Elevation](https://beyondelevation.com). The engagement delivers a scored portfolio, a prioritised remediation roadmap, and a clear dollar estimate of the value unlocked by closing each gap. Rated 4.5 stars on Trustpilot. --- ### You just read the framework. Now price your own IP. Beyond Elevation runs a 60-minute IP & licensing diagnostic for founders raising Seed–Series B. You leave with: (1) a defensibility score, (2) the royalty range your current portfolio supports, (3) the next 3 filings ranked by exit-multiple impact. No deck. No proposal. One call, one number. [Book the diagnostic →](https://usemotion.com/meet/hayat-amin/be?ref=blog-ip-defensibility-assessment-framework) *14 founders booked this month. Hayat takes 4/week.* --- ## FAQ ### How long does an IP defensibility assessment take? A full IP defensibility assessment typically takes 2 to 4 weeks depending on portfolio size. Portfolios with fewer than 10 patents complete in 2 weeks. Larger portfolios with international filings and complex claim structures require 3 to 4 weeks for thorough claim-level analysis. ### How much does an IP defensibility assessment cost? Professional IP defensibility assessments range from $8K to $25K depending on portfolio complexity. The investment regularly pays for itself by eliminating $30K to $100K in unnecessary filings and identifying licensing opportunities that were previously invisible. ### Can I run an IP defensibility assessment on a single patent? Yes. The 7-Point Test applies to single patents — a single patent can score 5 or above if the claims are broad, the technology is difficult to design around, and the patent maps to revenue. Single-patent assessments typically complete in one week at lower cost. ### What is a good IP defensibility score? A score of 5 out of 7 or above indicates an investor-ready portfolio with genuine commercial defensibility. Scores of 3 to 4 indicate moderate defensibility with fixable gaps. Below 3 means the portfolio needs significant strategic redesign before it can be presented to investors or licensing counterparties. ### Should I run an IP defensibility assessment before fundraising? Always. Running the assessment before fundraising gives you time to remediate gaps and present investors with a scored portfolio that demonstrates strategic IP management. Investors who see a 7-Point Test score above 5 price the company differently than investors who see an unaudited patent list. --- *Published on [Beyond Elevation](https://beyondelevation.com) — IP Strategy & Licensing Revenue Consultancy*